✦ LIBER ✦

Combining interferon with cytotoxic chemotherapy in patients with advanced breast cancer

✍ Scribed by Richard Ashford; Terence Priestman; Terence Mott; Juliana M. Bottomley

Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 297 KB
Volume: 23
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf00205653

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive short-term chemotherapy in pat

Intensive short-term chemotherapy in patients with advanced breast cancer

✍ Wander, H. -E. ;Nagel, G. A. ;Luig, H. ;Emrich, D. 📂 Article 📅 1987 🏛 Springer-Verlag 🌐 English ⚖ 636 KB

Combined treatment by chemotherapy and i

Combined treatment by chemotherapy and intravenous hyperalimentation in Japanese patients with advanced breast cancer

✍ Takeshi Tominaga; Tokio Onodera; Masatsugu Kitamura; Hajime Kaneko; Kazuo Hayash 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Ifosfamide combination chemotherapy in a

Ifosfamide combination chemotherapy in advanced breast cancer

✍ Hans Schmid; Manfred Kaufmann; Eva-Maria Grischke; Gunther Bastert 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 249 KB

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

✍ Stephen E. Jones; Brian G. M. Durie; Sydney E. Salmon 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Combination chemotherapy and adriamycin

Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study

✍ B. Hoogstraten; S. L. George; B. Samal; S. E. Rivkin; J. J. Costanzi; J. D. Bonn 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

First-line combination chemotherapy with

First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer

✍ P. Periti; G. Robustelli Delia Cuna; F. Pannuti; T. Mazzei; P. Preti; A. Martoni 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 312 KB

In this study, 30 evaluable patients with advanced carcinoma of the breast were treated with cyclophosphamide 600 mg/m2 i.v. followed one day later with mitoxantrone (Novantrone; dihydroxyanthracenedione) 16 mg/m2 i.v. Drug treatment was repeated every 3-4 weeks, for a maximum of 12 cycles. The over